The U.S. is experiencing a severe flu season, with infections surpassing last winter’s levels. The H3N2 strain, particularly the new K variant, is prevalent, raising concerns about vaccine effectiveness. Despite the surge, the Trump administration has stopped recommending flu vaccines for children, shifting the decision to parents and doctors. This policy change coincides with a halt in Medicaid immunization reporting, potentially impacting public health data. The flu season’s peak is anticipated, with significant implications for healthcare providers and policymakers.
